
09.11.2023
Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
04.05.2023
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
Genekam developed potential therapeutic human anitbodies against Chlamydia